ロード中...
Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
BACKGROUND: The United States (US) Food and Drug Administration (FDA) is responsible for the protection of the public health by assuring the safety, effectiveness and security of human drugs and biological products through the enforcement of the Federal Food, Drug and Cosmetic Act (FDCA) and related...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582490/ https://ncbi.nlm.nih.gov/pubmed/23339419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-13-27 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|